(Q38524558)

3 September 2017

1 reference

title

Comprehensive Review on the Surrogate Endpoints of Efficacy Proposed or Hypothesized in the Scientific Community Today (English)

1 reference

3 September 2017

Gunter von Minckwitz

1

1 reference

3 September 2017

Caterina Fontanella

series ordinal

2

1 reference

3 September 2017

publication date

1 May 2015

1 reference

Journal of the National Cancer Institute Monographs

3 September 2017

published in

1 reference

3 September 2017

volume

2015

1 reference

3 September 2017

issue

51

1 reference

3 September 2017

page(s)

29-31

1 reference

Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Surrogate endpoints in clinical trials: definition and operational criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Meta-analysis of the association of breast cancer subtype and pathologic complete response to neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Bevacizumab added to neoadjuvant chemotherapy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCIMONOGRAPHS%2FLGV007

10.1093/JNCIMONOGRAPHS/LGV007

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference